Table 1. Relationship between CA IX expression and clinico-pathological features.
Variables | Total | 1–25% | 26–50% | 51–75% | 76–100% | P-valuea |
---|---|---|---|---|---|---|
Age tertile | NSb | |||||
<61 | 20 | 6 | 5 | 6 | 3 | |
61.1–71.9 | 22 | 7 | 8 | 3 | 4 | |
⩾72 | 30 | 3 | 14 | 10 | 3 | |
Type | NS | |||||
Nonmucinous | 66 | 15 | 23 | 18 | 10 | |
Mucinous | 6 | 1 | 4 | 1 | ||
Site | NS | |||||
Left colon | 3 | 1 | 1 | 1 | ||
Caecum | 17 | 4 | 8 | 5 | ||
Right colon | 4 | 1 | 1 | 1 | 1 | |
Transverse, splenic | 3 | 1 | 2 | |||
Rectum | 24 | 5 | 8 | 8 | 3 | |
Rectum-sigmoid | 8 | 2 | 3 | 1 | 2 | |
Sigmoid | 13 | 4 | 5 | 3 | 1 | |
Size median | NS | |||||
<Median | 28 | 5 | 11 | 10 | 2 | |
⩾Median | 44 | 11 | 16 | 9 | 8 | |
Dukes' stage | <0.01 | |||||
A | 18 | 10 | 3 | 4 | 1 | |
B | 32 | 6 | 21 | 4 | 1 | |
C | 22 | 3 | 11 | 8 | ||
Differentiation | 0.01 | |||||
Moderate | 4 | 1 | 1 | 1 | 1 | |
Well | 62 | 14 | 25 | 18 | 5 | |
Poor | 6 | 1 | 1 | 3 | 1 | |
Metastasis | 0.01 | |||||
Primary | 72 | 16 | 27 | 19 | 10 | |
Secondary | 13 | 2 | 5 | 4 | 2 | |
Lymphatic metastasis | 0.01 | |||||
At DXc | 24 | 1 | 4 | 11 | 8 | |
During FUd | 2 | 1 | 1 | |||
No metastasis | 46 | 14 | 22 | 8 | 2 | |
Vascular metastasis | 0.05 | |||||
<Median | 37 | 6 | 16 | 9 | 6 | |
⩾Median | 35 | 10 | 11 | 10 | 4 | |
Lymph node metastasis | 0.02 | |||||
No | 43 | 14 | 20 | 8 | 1 | |
Yes | 29 | 2 | 7 | 11 | 9 | |
Death | 0.03 | |||||
No | 28 | 10 | 9 | 6 | 3 | |
Yes | 44 | 6 | 18 | 13 | 7 | |
Recurrence | 0.02 | |||||
Yes | 25 | 1 | 9 | 9 | 6 | |
No | 42 | 14 | 17 | 8 | 3 | |
NA | 5 | 1 | 1 | 2 | 1 | |
Gender | NS | |||||
Male | 42 | 9 | 13 | 13 | 7 | |
Female | 30 | 7 | 14 | 6 | 3 |
P-value by multivariate regression analysis.
Not significant.
At Dukes' C.
Nodal recurrence.